Luana Licata
Overview
Explore the profile of Luana Licata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
2880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arpaia V, Pirolo L, Sfregola S, Licata L, Iovino M, Sanduzzi L, et al.
Radiol Case Rep
. 2024 Sep;
19(11):5474-5480.
PMID: 39285970
Uterine lipoleiomyosarcomas (L-LMS) are rare malignant tumors with only few cases descripted in literature. As well, liposarcomas (LPS) arising from uterine corpus are extremely rare since fat tissue is commonly...
2.
Arora C, Matic M, Bisceglia L, Di Chiaro P, De Oliveira Rosa N, Carli F, et al.
Cell Genom
. 2024 May;
4(5):100557.
PMID: 38723607
We explored the dysregulation of G-protein-coupled receptor (GPCR) ligand systems in cancer transcriptomics datasets to uncover new therapeutics opportunities in oncology. We derived an interaction network of receptors with ligands...
3.
Iannuccelli M, Vitriolo A, Licata L, Lo Surdo P, Contino S, Cheroni C, et al.
Mol Psychiatry
. 2024 Jan;
29(1):197.
PMID: 38267621
No abstract available.
4.
Iannuccelli M, Vitriolo A, Licata L, Lo Surdo P, Contino S, Cheroni C, et al.
Mol Psychiatry
. 2023 Dec;
29(1):186-196.
PMID: 38102483
Autism spectrum disorder (ASD) comprises a large group of neurodevelopmental conditions featuring, over a wide range of severity and combinations, a core set of manifestations (restricted sociality, stereotyped behavior and...
5.
Simona P, Panneerselvam K, Porras P, Duesbury M, Perfetto L, Licata L, et al.
Database (Oxford)
. 2023 Oct;
2023.
PMID: 37819683
In recent years, a huge amount of data on ncRNA interactions has been described in scientific papers and databases. Although considerable effort has been made to annotate the available knowledge...
6.
Arora C, Matic M, DiChiaro P, De Oliveira Rosa N, Carli F, Clubb L, et al.
bioRxiv
. 2023 Jul;
PMID: 37398064
We explored the dysregulation of GPCR ligand signaling systems in cancer transcriptomics datasets to uncover new therapeutics opportunities in oncology. We derived an interaction network of receptors with ligands and...
7.
Licata L, Via A, Turina P, Babbi G, Benevenuta S, Carta C, et al.
Front Mol Biosci
. 2023 May;
10:1169109.
PMID: 37234922
Collectively, rare genetic disorders affect a substantial portion of the world's population. In most cases, those affected face difficulties in receiving a clinical diagnosis and genetic characterization. The understanding of...
8.
Deutsch E, Vizcaino J, Jones A, Binz P, Lam H, Klein J, et al.
J Proteome Res
. 2023 Jan;
22(2):287-301.
PMID: 36626722
The Human Proteome Organization (HUPO) Proteomics Standards Initiative (PSI) has been successfully developing guidelines, data formats, and controlled vocabularies (CVs) for the proteomics community and other fields supported by mass...
9.
Lo Surdo P, Iannuccelli M, Contino S, Castagnoli L, Licata L, Cesareni G, et al.
Nucleic Acids Res
. 2022 Oct;
51(D1):D631-D637.
PMID: 36243968
The SIGnaling Network Open Resource (SIGNOR 3.0, https://signor.uniroma2.it) is a public repository that captures causal information and represents it according to an 'activity-flow' model. SIGNOR provides freely-accessible static maps of...
10.
Iannuccelli M, Lo Surdo P, Licata L, Castagnoli L, Cesareni G, Perfetto L
Front Mol Biosci
. 2022 Jun;
9:893256.
PMID: 35664677
Some inherited or somatically-acquired gene variants are observed significantly more frequently in the genome of cancer cells. Although many of these cannot be confidently classified as driver mutations, they may...